These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26660639)

  • 21. Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients.
    Genre F; López-Mejías R; Miranda-Filloy JA; Ubilla B; Carnero-López B; Gómez-Acebo I; Blanco R; Ochoa R; Rueda-Gotor J; Pina T; González-Juanatey C; Llorca J; González-Gay MA
    Ann Rheum Dis; 2014 May; 73(5):941-3. PubMed ID: 24323393
    [No Abstract]   [Full Text] [Related]  

  • 22. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.
    Braun J; Davis J; Dougados M; Sieper J; van der Linden S; van der Heijde D;
    Ann Rheum Dis; 2006 Mar; 65(3):316-20. PubMed ID: 16096329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current therapy with TNFalpha blocking agents for ankylosing spondylitis and undifferentiated spondyloarthritis].
    Brandt J; Sieper J; Braun J
    Z Rheumatol; 2004 Jun; 63(3):203-10. PubMed ID: 15224223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?
    Sieper J; Rudwaleit M
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv61-4. PubMed ID: 16239391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of overexpressed variable heavy chain 2 transcripts with tumor necrosis factor inhibitors in ankylosing spondylitis.
    Sheen DH; Kim JY; Lee SY; Lim MK; Yoo SJ; Yoo IS; Kim J; Kang SW; Shim SC
    J Rheumatol; 2014 Mar; 41(3):613-4. PubMed ID: 24585525
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of ankylosing spondylitis.
    Clegg DO
    J Rheumatol Suppl; 2006 Sep; 78():24-31. PubMed ID: 17042057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?
    Gaspersic N; Sersa I; Jevtic V; Tomsic M; Praprotnik S
    Ann Rheum Dis; 2008 Sep; 67(9):1354. PubMed ID: 18697784
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous leishmaniasis in a patient with ankylosing spondylitis using adalimumab.
    Gomes KW; Benevides AN; Vieira FJ; Burlamaqui MP; Vieira Mde A; Fontenelle LM
    Rev Bras Reumatol; 2012; 52(3):447-52. PubMed ID: 22641598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
    Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lichen planus under anti TNF therapy for ankylosing spondylitis.
    Wendling D; Biver-Dalle C; Vidon C; Prati C; Aubin F
    Joint Bone Spine; 2013 Mar; 80(2):227-8. PubMed ID: 23453473
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study.
    Song IH; Heldmann F; Rudwaleit M; Haibel H; Weiss A; Braun J; Sieper J
    Ann Rheum Dis; 2011 Jun; 70(6):1108-10. PubMed ID: 21415053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor-α promoter -308/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-α and does not predict TNF inhibitor response.
    Nossent JC; Sagen-Johnsen S; Bakland G
    J Rheumatol; 2014 Aug; 41(8):1675-82. PubMed ID: 25028373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.
    Keat A; Barkham N; Bhalla A; Gaffney K; Marzo-Ortega H; Paul S; Rogers F; Somerville M; Sturrock R; Wordsworth P;
    Rheumatology (Oxford); 2005 Jul; 44(7):939-47. PubMed ID: 15901904
    [No Abstract]   [Full Text] [Related]  

  • 34. A major subset of patients with ankylosing spondylitis followed up in tertiary clinical care require anti-tumour necrosis factor alpha biological treatments according to the current guidelines.
    Temel M; Atagündüz P; Direskeneli H
    Ann Rheum Dis; 2005 Sep; 64(9):1383-4. PubMed ID: 16100352
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives?
    Kiltz U; Heldmann F; Baraliakos X; Braun J
    Curr Opin Rheumatol; 2012 May; 24(3):252-60. PubMed ID: 22450391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring patients with ankylosing spondylitis on anti-TNF monotherapy: too much too often?
    Gunasekera W; Creamer P; Creamer K; Sengupta R
    Scand J Rheumatol; 2017 Jul; 46(4):330-331. PubMed ID: 27733090
    [No Abstract]   [Full Text] [Related]  

  • 37. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
    Braun J; Baraliakos X; Listing J; Fritz C; Alten R; Burmester G; Krause A; Schewe S; Schneider M; Sörensen H; Zeidler H; Sieper J
    Ann Rheum Dis; 2008 Mar; 67(3):340-5. PubMed ID: 17967831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withdrawal of biologic therapy in axial spondyloarthritis: the experience in early disease.
    Song IH; Haibel H; Poddubnyy D; Braun J; Sieper J
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S37-42. PubMed ID: 24129135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study.
    Spadaro A; Lubrano E; Marchesoni A; D'Angelo S; Ramonda R; Addimanda O; Perrotta FM; Olivieri I; Punzi L; Salvarani C
    Rheumatology (Oxford); 2013 Oct; 52(10):1914-9. PubMed ID: 23878312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of methotrexate in patients with ankylosing spondylitis.
    Haibel H; Sieper J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S128-31. PubMed ID: 21044446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.